Consumer Staples
Household & Personal Products
$20.16B
8K
Key insights and themes extracted from this filing
Net earnings attributable to Clorox dramatically improved to $186 million for the three months ended March 31, 2025, from a loss of $51 million in the prior year, and to $478 million for the nine months from $64 million. This turnaround was primarily driven by a 240 basis point increase in gross margin to 44.6% (three months) and a 300 basis point increase to 44.7% (nine months), largely due to cost savings and divestiture benefits.
Net sales decreased 8% to $1,668 million for the three months ended March 31, 2025, and 1% to $5,116 million for the nine months, primarily due to the divestitures of the Better Health VMS and Argentina businesses. However, the Company reported positive organic sales growth of 4% for the nine-month period, partially offsetting the reported decline.
Net cash provided by operations nearly doubled, reaching $687 million for the nine months ended March 31, 2025, a significant increase from $355 million in the prior year. This improvement was attributed to higher cash earnings and lower tax payments, driven by deferred fiscal year 2023 income taxes.